Comprehensive Nursing Notes on Trauma, Abuse, and Suicide Prevention

Spectrum and Dynamics of Abuse

  • Child Maltreatment:

    • Child Abuse: Overt physical, emotional, or sexual actions causing direct harm to a child.
    • Child Neglect: Failure to provide basic biological, physical, educational, or emotional needs and protection from harm.
  • Elder Abuse & Intimate Partner Violence (IPV):

    • Elder Abuse: Physical, emotional, sexual abuse, or neglect; economic/financial abuse is the most prevalent type.
    • Intimate Partner Violence (IPV): Physical violence, stalking, sexual violence, and psychological aggression across all socioeconomic backgrounds.
    • Teen Partner Abuse: Prevalent in adolescent dating relationships.
  • Theoretical Frameworks:

    • Social Learning Theory: Intergenerational transmission of violence posits that experiencing or witnessing violence in childhood normalizes violent behaviors in adulthood.
    • Social-Ecologic Model: Evaluates individual risk intersecting with family, community economic disadvantage, and societal power imbalances.
  • Cycle of Violence:

    1. Tension-Building: Minor verbal or physical incidents occur; the victim feels like walking on eggshells and attempts to calm the abuser.
    2. Acute Battering: Release of tension through severe physical, emotional, or sexual violence, causing serious trauma or physical injuries.
    3. Honeymoon Phase: Abuser expresses deep remorse, promises reform, and offers gifts; tension gradually rebuilds, repeating the cycle with increased severity.
  • Clinical Priorities & Assessment:

    • Maslow's Priority: Prioritize immediate biological and safety needs (physical safety, medical stabilization, emergency shelter, nutrition) before processing psychological trauma.
    • Physical Cues: Bruises in various stages of healing, welts, burns, bite marks, subdural hematomas, missing hair, fearful or hyper/hypoactive demeanor, vague explanations for injuries, and a partner who answers for the patient.
    • Communication Guidelines: Conduct interviews in a quiet, private area; explain mandatory reporting limits early; use gradual, empathetic non-judgmental questioning; always use certified medical interpreters rather than family members.
    • Assessment Tools:
    • Abuse Assessment Screen (AAS): Detects presence of emotional, physical, or sexual abuse within intimate relationships.
    • Danger Assessment (DA): Evaluates risk of lethality or homicide in violent partner relationships.

Assessment Tools Comparison

  • Batterer Intervention Programs (BIPs):
    • Court-mandated outpatient programs lasting approximately ∼8 months\sim 8\text{ months}; evidence of efficacy is limited, and returning to an abuser in a BIP still poses high risk.

Suicide Risk Assessment and Nursing Care

  • Core Concepts:

    • Hopelessness: The profound belief that undesirable events are bound to occur and no action will improve the situation; primary emotional predictor of suicide risk.
    • Lethality: Potential of a chosen method to cause death; high-lethal methods (firearms, hanging) require immediate high-level restrictive security measures.
    • Screening Tool: Columbia-Suicide Severity Rating Scale (C-SSRS) is the gold standard screening tool for early case finding.
  • Evidence-Based Nursing Facts:

    • Direct inquiries about suicide reduce stigma, lower distress, and facilitate help-seeking; asking directly does not plant ideas.
    • Warning signs almost always precede suicidal behavior, and suicidal ideation is often short-term and situation-specific.
    • Suicide stems from an overwhelming urge to stop unendurable pain, not selfishness.
  • Assessment Factors:

    • Intent & Severity: Direct intent to die, prior attempts, ideation frequency/duration, and controllability.
    • Planning & Lethality: Degree of planning (specific timing/location), direct access to lethal means, and protective factors (family ties, spiritual beliefs, personal goals).
  • Inpatient Safety & Environmental Controls:

    • Environmental Safety: Search belongings to eliminate glass, sharps, belts, cords, and contraband.
    • Imminent / Severe Risk: Implement 1:11:1 continuous observation within arm's length.
    • Intermediate Risk: Perform 15-minute15\text{-minute} line-of-sight checks at random time intervals.
    • Outdated Protocols: Avoid "No-Suicide Contracts"; utilize collaborative Safety Plans and written Commitment to Treatment Statements (CTS).

Inpatient Safety and Environmental Control Strategies

  • Psychological & Biological Interventions:
    • Cognitive Distraction & Distress Tolerance: Disrupt repetitive loops using reading or guided imagery; teach grounding exercises (5-4-3-2-15\text{-}4\text{-}3\text{-}2\text{-}1 technique, deep breathing).
    • Pharmacotherapy:
    • Clozapine: FDA-approved specifically for reducing suicidal behavior in schizophrenia.
    • Lithium: Well-documented long-term anti-suicidal properties in Bipolar Disorder.
    • SSRIs: Preferred non-lethal antidepressant choice due to lower toxicity in overdose; monitor adolescents/young adults closely for initial titration Black Box Warnings.
    • Ketamine: Rapid-acting infusion therapy for treatment-resistant acute ideation.
    • Somatic Care: Electroconvulsive Therapy (ECT) is highly effective for severe, refractory depression with rapid suicidal drive reduction.

Trauma- and Stressor-Related Disorders

  • Diagnostic Criteria & Differential Diagnosis:

    • Acute Stress Disorder (ASD): Duration of 3 days to 1 month3\text{ days to }1\text{ month} post-trauma; temporary extreme stress reaction.
    • Posttraumatic Stress Disorder (PTSD): Symptoms persist >1 month> 1\text{ month} across 4 core clusters:
    1. Intrusion: Involuntary memories, nightmares, flashbacks, and trigger distress.
    2. Avoidance & Numbing: Avoiding trauma reminders/thoughts, emotional numbing, and social detachment.
    3. Negative Mood & Cognitions: Persistent negative beliefs, distorted self-blame, persistent fear/guilt/shame, and anhedonia.
    4. Hyperarousal & Reactivity: Irritability, aggressive outbursts, hypervigilance, exaggerated startle response, and insomnia.
    • Complex PTSD (CPTSD): Results from chronic, repetitive trauma over months/years; presents with core PTSD symptoms plus severe affective dysregulation, negative self-concept, and relational disruption.
  • Epidemiology & High-Risk Populations:

    • General Population: Lifetime prevalence is ∼6%\sim 6\% in the U.S.; higher in females (9.7%9.7\%) than males (3.6%3.6\%).
    • Deployed Veterans: Prevalence up to 15.7%15.7\% (∼20%\sim 20\% in female veterans); high comorbidity with alcohol misuse, traumatic brain injury (TBI), and suicide risk.
    • Children (≤6 years\le 6\text{ years}): Express trauma through repetitive play, night terrors without clear content, and separation anxiety.
  • Etiology & Neurobiology:

    • Neurostructural Changes: Hyperactive amygdala (drives emotional reactivity/fear conditioning), decreased hippocampal volume (impairs context processing/memory consolidation), and hypoactive prefrontal cortex (reduced top-down inhibition).
    • Neurochemical Changes: Norepinephrine hyperactivity in the locus coeruleus leads to autonomic arousal, insomnia, and exaggerated startle response.
  • Evidence-Based Interventions:

    • Psychotherapies: Cognitive Behavioral Therapy (CBT), Exposure Therapy, Cognitive Processing Therapy (CPT), Stress Inoculation Training (SIT), Eye Movement Desensitization & Reprocessing (EMDR), and Virtual Reality Exposure (VRET).
    • Pharmacotherapy:
    • Sertraline (Zoloft): 25 mg PO qAM×1 wk25\,\text{mg}\text{ PO qAM} \times 1\text{ wk}, then 50 mg PO daily50\,\text{mg}\text{ PO daily}; FDA-approved for core PTSD symptoms.
    • Paroxetine (Paxil): FDA-approved SSRI; monitor 2 to 4 weeks2\text{ to }4\text{ weeks} for therapeutic onset and suicide risk.
    • Prazosin (Minipress): Alpha-1 blocker used off-label for trauma nightmares and sleep disruption; monitor for orthostatic hypotension.
    • Adjuncts: Zolpidem (Ambien) 5 mg PO HS PRN5\,\text{mg}\text{ PO HS PRN} for short-term insomnia; Lorazepam (Ativan) 1 mg q4-6h PRN1\,\text{mg}\text{ q4-6h PRN} for acute anxiety.
    • Trauma-Informed Care Principles: Safety, Trustworthiness, Choice, Collaboration, and Empowerment.
  • Dissociative & Pediatric Attachment Disorders:

    • Dissociative Amnesia & Depersonalization/Derealization: Inability to recall personal trauma; feelings of detachment from body ("outside observer") or environment.
    • Dissociative Identity Disorder (DID): Presence of 2 or more distinct personality states (alters) controlling behavior; stems from an unconscious defense mechanism against severe repetitive childhood abuse (1.1% to 1.5%1.1\% \text{ to } 1.5\% prevalence).
    • Reactive Attachment Disorder (RAD): Inhibited, emotionally withdrawn behavior toward adult caregivers due to severe emotional neglect; child rarely seeks or responds to comfort.
    • Disinhibited Social Engagement Disorder (DSED): Child actively approaches and interacts with unfamiliar adults without hesitation; creates a high risk for exploitation due to lack of stranger boundaries.